covid-19 ‚Äì does this disease kill due to imbalance of the renin angiotensin system (ras) caused by genetic and gender differences in the response to viral ace 2 attack. ¬© 2020 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ)Debate continues in the medical literature on the role of the renin angiotensin system (RAS) in Coronavirus disease 2019 (COVID-19) pathophysiology and the implications for the use of cardiovascular drugs acting on the RAS. Could these drugs ‚Äì which include angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptors blockers (ARBs) ‚Äì be harmful or potential key therapeutic agents in COVID-19? And, could potentially helpful measures be available and in plain view on the pharmacy shelf?